Scientists Just Found a Novel, Cheap Way to Use CRISPR Gene Editing to Fight Cancer
The CRISPR research was backed by Sean Parker's cancer immunotherap.....»»
Cellectis wins patent challenge in Europe for CRISPR-Cas9 gene editing method
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
CRISPR Therapeutics stock jumps on early gene editing data
Cambridge startup CRISPR Therapeutics and partner Vertex Pharmaceuticals reached what executives called a significant step this week, releasing promising early data on a drug designed to alter a person's DNA and potentially cure them of a disease......»»
The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout
Here's a r.....»»
CRISPR gene editing startup Beam Therapeutics plans $100M IPO
Mere months after raising $135 million from investors, another gene editing startup co-founded by MIT researcher Feng Zhang is preparing to go public. Cambridge’s Beam Therapeutics filed documents with the SEC after markets closed Friday disclosin.....»»
Your Digital Self: CRISPR gene-editing technique set to push new boundaries
Biotechnology companies are seeking to cure forms of blindness, muscular dystrophy and leukemia......»»
Gene Therapy vs. Gene Editing: Which Is Better for Tackling Muscular Dystrophy?
Vertex Pharmaceuticals recently doubled down on its gene editing collaboration with CRISPR Therapeutics, but it's miles behind an arguably simpler solution......»»
Crispr"s expanded Vertex deal validates gene editing platform, says Wells Fargo
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mitalipov responds to backlash against gene editing, following Chinese experiment
Shoukhrat Mitalipov, who directs the OHSU Center for Embryonic and Gene Therapy, is pushing back against calls for a moratorium on using gene-editing tools to prevent inherited disease. Miltalipov was among the many scientists condemning an experime.....»»
When Will Gene Editing Help Humans? This Investor Says It’s Already Happening
Startup Tmunity is now in clinical trials with a cancer gene-killing treatment. The news came at the Fortune Brainstorm Health conference. Technology has long infused health care with inspiration and hope. Th.....»»
Better Buy: CRISPR Therapeutics vs. Sangamo Therapeutics
Which of these gene editing stocks will come out on top?.....»»
Scientists From Around The World Call For Immediate Halt To Gene-Editing Of Humans
Authored by Derrick Broze via TheMindUnleashed.com, .....»»
Scientists discover work around to cancer concern with CRISPR, STAT says
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Brainstorm Health: AI and Old Drugs, Gene Editing Registry, AbbVie Cancer Drug
Brainstorm Health Daily.....»»
Brainstorm Health: Alex Trebek Cancer, China Gene Editing Rules, Gilead Shakeup
Brainstorm Health Daily: March 7, 2019 Good afternoon, readers. Busy times around here with a magazine deadline looming, so it’ll have to be a short one from me today. One note/mea cul.....»»
Breakthrough CRISPR Gene Editing Trial Set to Begin This Year
Researchers think this trial could be "the real beginning of gene therapy.".....»»
Goldman Sachs: China Is Beating the U.S. in the Gene Editing Arms Race
On hot technologies like CRISPR and CAR-T, China has a leg up, Goldman says......»»
Can the Gene-Editing Technology CRISPR Cure This Debilitating Brain Disease?
Is CRISPR the miracle we've been hoping for to treat genetic brain diseases?.....»»
CRISPR, Vertex say FDA puts brakes on upcoming gene editing trial
Cambridge startup CRISPR Therapeutics and Boston-based Vertex Pharmaceuticals said on Wednesday that the FDA has put on hold a highly anticipated upcoming trial of their experimental gene editing drug for sickle cell disease. CRISPR (Nasdaq: CRIS.....»»
Is CRISPR in Touble After New STAT Report?
Shares of CRISPR Therapeutics tumbled after a report was released that gene-edited cells might cause cancer. The implications of this study could be catastrophic for the company seeing as CRISPR is........»»
Gene-Editing Selloff Is Overdone
The science-journal studies that ignited a rout in Crispr Therapeutics, Editas Medicine, and other gene-therapy shares look to have been misunderstood......»»